Healthtech

In healthtech, the margin for communications error is narrow. The audiences — clinicians, patients, healthcare institutions, regulators and investors — each bring high levels of domain expertise and correspondingly high credibility requirements. A claim that is accurate but imprecisely expressed, or a narrative that overstates clinical evidence, can cause more damage than no communication at all.

What makes healthtech communications different

Most industries allow a degree of aspirational language. Healthtech does not. The story must be grounded in what has been demonstrated, what has regulatory support and what is genuinely in the patient's interest. The best healthtech communications is not timid — it is precise. There is a significant difference between the two, and the gap between them is where most healthtech brands struggle.

Navigating multiple high-stakes audiences

• Clinical audiences — want evidence, methodology, peer validation; respond badly to marketing language
• Patient audiences — want reassurance, clarity and genuine empathy; the stakes are personal
• Institutional buyers — want proof of outcomes, integration capacity and regulatory compliance
• Investors — want addressable market size, clinical validation and a clear path to scale
• Regulators — want accuracy, transparency and proactive engagement

Trust as the only metric that matters

Every communications decision in healthtech should be tested against a single question: does this build or erode trust? The brands that have navigated this sector well — earning clinical adoption, patient confidence and institutional partnerships — are the ones that treated trust not as a communications outcome but as the product itself.